Prognosis and risk assessment in AL amyloidosis – state of the art

Efstathios Kastritis; Meletios A Dimopoulos

doi:10.3109/13506129.2011.574354032

Abstract

1 min read

Abstract: The management of patients with AL requires meticulous risk assessment in order to plan treatment strategy and reduce the risk of treatment related complications. The most important progn...

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Letter2017

Prognosis and risk assessment in AL amyloidosis - There and back again

Efstathios Kastritis, Meletios A Dimopoulos

Article2022

Future Developments in the Treatment of AL Amyloidosis

Foteini Theodorakakou, Despina Fotiou, Meletios A Dimopoulos, Efstathios Kastritis

Article2012

Outcomes of Primary Systemic Light Chain (AL) Amyloidosis in Patients Treated Upfront with Novel Agents and the Importance of Risk Adapted Treatment Strategies

Efstathios Kastritis, Μαρία Ρούσσου, Maria Gavriatopoulou, Magdalini Migkou, Alexandra Gkougkoutsi, Constantinos Pamboukas, Elisavet Kaldara, Argirios Dalianis, Erasmia Psimenou, Savvas Toumanidis, Evangelos Terpos, Meletios A Dimopoulos

Article2020

Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID‐19 pandemic

Efstathios Kastritis, Ashutosh Wechalekar, Stefan Schönland, Vaishali Sanchorawala, Giampaolo Merlini, Giovanni Palladini, Monique C. Minnema, Murielle Roussel, Arnaud Jaccard, Ute Hegenbart, Shaji Kumar, María Teresa Cibeira, Joan Bladé, Meletios A Dimopoulos

Article2018

Clinical scores used for the prediction of negative events in patients undergoing catheter ablation for atrial fibrillation

Falco Kosich, Katja Schumacher, Tatjana Potpara, Professor Gregory Lip, Gerhard Hindricks, Jelena Kornej